Navigation Links
Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
Date:2/29/2008

es and recent corporate developments. To access the live conference call, U.S. and

Canadian participants may dial 1-866-966-5335; international participants may dial 44-20-3023-4460. To access the 24-hour audio replay, U.S. and Canadian participants may dial 1-866-583-1035; international participants may dial 44-20-8196-1996. The access code for the replay is 181543#. The replay will be available until March 7, 2008.

A live audio webcast of the call will also be available on the "Investors" section of the company's website http://www.rosettagenomics.com. An archived webcast will be available on the Company's website approximately two hours after the event, and will be archived for 30 days thereafter.

About microRNAs

MicroRNAs (miRNAs) are recently discovered, naturally occurring small RNAs that act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNAs have been shown to have different expression in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leading molecular diagnostics company developing microRNA-based technologies used in the development of diagnostic tests and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discover
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Rosetta Genomics Establishes Medical Advisory Board
2. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
3. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
4. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
5. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
6. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
7. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
8. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014 Each year in the ... medical attention. In the military, burn injury is ... battlefield medical care. More than 800 service members ... wounds heal slowly, remain inflamed and often become ... debilitating and functionally damaging. While developments in supportive ...
(Date:9/29/2014)... start of the military conflicts in Iraq and Afghanistan, ... States with traumatic brain injury caused by exposure to ... explosive devices, or IEDs. Symptoms of traumatic brain injury ... and nausea, to more severe impairments in memory and ... Defense has recognized the critical importance and complexity of ...
(Date:9/29/2014)... Research and Markets  has announced the ... & Services, End-User , Application - Global Forecast to ... The global oligonucleotide synthesis market is expected to reach ... growing at a CAGR of 9.8% from 2014 to ... the basis of products and services, applications, end users, ...
(Date:9/29/2014)... diseases and biodiversity loss requires evolutionary thinking, argues ... Express that was co-authored by Bruce Tabashnik ... and Life Sciences. , For the first time, ... progress in addressing a broad set of challenges ... that consider evolutionary histories and the likelihood of ...
Breaking Biology Technology:Faster Healing with Fewer Scars 2Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3
... Food Safety Authority (EFSA) concludes no safety concerns for ... response to Nutrition 21,s Application to market Chromax(R) chromium ... PURCHASE, N.Y., June 30 Nutrition 21, Inc. (Nasdaq: ... nutritional supplements under the Iceland Health(R) and Diabetes Essentials ...
... SEATTLE, June 30 Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: ... 3000(R), Russell 2000(R) and Russell Global(R) Indexes posted by Russell Investments ... Russell Investments reconstitutes its family of U.S. and global equity indexes ... of Russell,s U.S. indexes captures the 4,000 largest U.S. stocks as ...
... , FRANKLIN LAKES, N.J., June 29 BD (Becton, ... it will conduct a live webcast of its third fiscal quarter ... a.m. (EDT). BD will issue a press release detailing the ... the conference call, along with related slides, will be accessible through ...
Cached Biology Technology:EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 2EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 3EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements 4Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes 2Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes 3
(Date:9/29/2014)... found that a combination of a real-time feedback system ... of residence resulted in a reduction of 37% in ... were 1360.49 kWh, which is equivalent to a reduction ... weeks. , In contrast, another eight halls, exposed ... alert, resulted in saw a 3.5% reduction in energy ...
(Date:9/29/2014)... dabrafenib has significant anti-tumour activity in patients with ... whose disease has progressed after chemotherapy, according to ... Congress in Madrid, Spain. , "Reports of ... considerable interest because these mutations may be associated ... says lead author Dr David Planchard, pulmonary oncologist ...
(Date:9/29/2014)... DNA from the skeleton of a man who lived 2,330 ... about ourselves as humans? A great deal when his DNA ... genetic terms found to-date in a region where modern ... , The man,s maternal DNA, or ,mitochondrial DNA, was ... evolution. Mitochondrial DNA provided the first evidence that we all ...
Breaking Biology News(10 mins):Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3Ancient human genome from southern Africa throws light on our origins 2Ancient human genome from southern Africa throws light on our origins 3
... Comfortable living is not why so many different life ... the planet. , Writing this week in the Proceedings ... temperatures near the equator speed up the metabolisms of ... the creation of new species. , The finding - ...
... the rewarding effect of cocaine on mice by genetically ... animal's brain. , While the researchers aren't suggesting that ... brings to light the key protein that controls cocaine's ... medications that achieve the same results and therefore help ...
... remember learning to swim? Thrashing around, floundering, until suddenly ... strokes of doggy-paddle propel you away from your parent's ... expert swimmers. Actually, fish larvae are pretty feeble when ... 'burst-and-coast'. Dr Ulrike Müller from Wageningen University studies how ...
Cached Biology News:Taking evolution's temperature: Researchers pinpoint the energy it takes to make a species 2Taking evolution's temperature: Researchers pinpoint the energy it takes to make a species 3Genetically altered mice no longer like cocaine 2Genetically altered mice no longer like cocaine 3Even fish don't swim well when they're young! 2
...
Contains L-glutamine....
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
...
Biology Products: